Findings

What do systematic reviews say?

10 questions · 10 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 20%Moderate 6 · 60%High 2 · 20%

Multiple treatment of beta₂‐agonist via spacer (chamber) vs nebuliser

Hospital admissions · children with acute asthma

Multiple treatment of beta₂‐agonist via spacer (chamber) showed no clear difference in hospital admission compared with nebuliser (low certainty).

1 finding from 1 review

Holding chambers (spacers) versus nebulisers for beta‐agonist treatment of acute asthma 2013 · Cochrane Headline outcomes only
RR 0.71 [0.47, 1.08]
9 studies · 757 participants
Low

Multiple treatment of beta₂‐agonist via spacer (chamber) vs nebuliser

Tremor · Adults with acute asthma

Multiple treatment of beta₂‐agonist via spacer (chamber) showed no clear difference in number of participants developing tremor compared with nebuliser (moderate certainty).

1 finding from 1 review

Holding chambers (spacers) versus nebulisers for beta‐agonist treatment of acute asthma 2013 · Cochrane Headline outcomes only
RR 1.12 [0.66, 1.9]
4 studies · 234 participants
Moderate

Multiple treatment of beta₂‐agonist via spacer (chamber) vs nebuliser

Duration in emergency department (minutes) · children with acute asthma

1 finding from 1 review

Holding chambers (spacers) versus nebulisers for beta‐agonist treatment of acute asthma 2013 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 396 participants
Moderate

Multiple treatment of beta₂‐agonist via spacer (chamber) vs nebuliser

Final rise in FEV₁ (% predicted) · children with acute asthma

1 finding from 1 review

Holding chambers (spacers) versus nebulisers for beta‐agonist treatment of acute asthma 2013 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 48 participants
Low

Multiple treatment of beta₂‐agonist via spacer (chamber) vs nebuliser

Rise in pulse rate (% baseline) · children with acute asthma

1 finding from 1 review

Holding chambers (spacers) versus nebulisers for beta‐agonist treatment of acute asthma 2013 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 670 participants
Moderate

Multiple treatment of beta₂‐agonist via spacer (chamber) vs nebuliser

Tremor · children with acute asthma

Multiple treatment of beta₂‐agonist via spacer (chamber) probably leads to lower number of participants developing tremor compared with nebuliser (moderate certainty).

1 finding from 1 review

Holding chambers (spacers) versus nebulisers for beta‐agonist treatment of acute asthma 2013 · Cochrane Headline outcomes only
RR 0.64 [0.44, 0.95]
4 studies · 254 participants
Moderate

Multiple treatment of beta₂‐agonist via spacer (chamber) vs nebuliser

Hospital admissions · Adults with acute asthma

Multiple treatment of beta₂‐agonist via spacer (chamber) showed no clear difference in hospital admission compared with nebuliser (moderate certainty).

1 finding from 1 review

Holding chambers (spacers) versus nebulisers for beta‐agonist treatment of acute asthma 2013 · Cochrane Headline outcomes only
RR 0.94 [0.61, 1.43]
9 studies · 582 participants
Moderate

Multiple treatment of beta₂‐agonist via spacer (chamber) vs nebuliser

Duration in emergency department (minutes) · Adults with acute asthma

1 finding from 1 review

Holding chambers (spacers) versus nebulisers for beta‐agonist treatment of acute asthma 2013 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 132 participants
Moderate

Multiple treatment of beta₂‐agonist via spacer (chamber) vs nebuliser

Final rise in FEV₁ (% predicted) · Adults with acute asthma

1 finding from 1 review

Holding chambers (spacers) versus nebulisers for beta‐agonist treatment of acute asthma 2013 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 307 participants
High

Multiple treatment of beta₂‐agonist via spacer (chamber) vs nebuliser

Rise in pulse rate (% baseline) · Adults with acute asthma

1 finding from 1 review

Holding chambers (spacers) versus nebulisers for beta‐agonist treatment of acute asthma 2013 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 376 participants
High